Cargando…

Co-morbidity burden in Parkinson’s disease: Comparison with controls and its influence on prognosis

BACKGROUND: Many aspects of co-morbidity burden in Parkinson’s disease (PD) are unclear, but it may be an important predictor of prognosis or confounder of associations in epidemiological studies. OBJECTIVES: To determine how best to assess co-morbidity burden in PD, to compare with matched controls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macleod, Angus D., Goddard, Hannah, Counsell, Carl E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925465/ https://www.ncbi.nlm.nih.gov/pubmed/27210815 http://dx.doi.org/10.1016/j.parkreldis.2016.05.013

Ejemplares similares

Predictors of functional dependency in Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2016)

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
por: Counsell, Carl, et al.
Publicado: (2022)

Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2017)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
por: Green, Samantha, et al.
Publicado: (2021)

Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study
por: Cumming, Kirsten, et al.
Publicado: (2017)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
por: Fielding, S., et al.
Publicado: (2016)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Co-morbidities of persons dying of Parkinson's disease
por: Lethbridge, Lynn, et al.
Publicado: (2013)

Neuropsychiatric co-morbidities in non-demented Parkinson's disease
por: Rai, Nirendra Kumar, et al.
Publicado: (2015)

The Influence of Life Experiences on the Development of Resilience in Older People With Co-morbid Health Problems
por: Windle, Gill, et al.
Publicado: (2020)

Management of Parkinson’s disease challenged by co-morbid drug abuse
por: Simas, J., et al.
Publicado: (2022)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Infuence of co-morbidity in the prognosis of politrauma in geriatric patients
por: Famà, F, et al.
Publicado: (2011)

Cardiovascular co-morbidity in rheumatic diseases
por: Turesson, Carl, et al.
Publicado: (2008)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders
por: Kohane, Isaac S., et al.
Publicado: (2012)

Extraordinary disease burden: an analysis of multi-morbidity
por: Ratcliffe, KM, et al.
Publicado: (2009)

The puzzle of long-term morbidity after critical illness
por: Wunsch, Hannah, et al.
Publicado: (2010)

Morbidity in early Parkinson's disease and prior to diagnosis
por: Frandsen, Rune, et al.
Publicado: (2014)

Peripheral aetiopathogenic drivers and mediators of Parkinson’s disease and co-morbidities: role of gastrointestinal microbiota
por: Dobbs, Sylvia M., et al.
Publicado: (2015)

Deep Brain Stimulation Target Selection in Co-Morbid Essential Tremor and Parkinson’s Disease
por: Wadhwa, Anant, et al.
Publicado: (2020)

A systematic review of biomarkers for disease progression in Parkinson’s disease
por: McGhee, David JM, et al.
Publicado: (2013)

Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable
por: Moore, Kelly L., et al.
Publicado: (2018)

Impact of weight trajectory after bariatric surgery on co-morbidity evolution and burden
por: Davis, Jason A., et al.
Publicado: (2020)

2212. Burden of Community-Acquired Pneumonia Attributable to Co-morbid Conditions in Adults
por: Rolfes, Melissa A, et al.
Publicado: (2019)

Quality of life predicts rehabilitation prognosis in Parkinson's disease patients: Factors influence rehabilitation prognosis
por: Meng, Detao, et al.
Publicado: (2022)

Patient-Related Factors Influencing Caregiver Burden in Parkinson’s Disease Patients: Comparison of Effects Before and After Deep Brain Stimulation
por: Van Hienen, Marle M., et al.
Publicado: (2022)

Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
por: Patel, Sneha, et al.
Publicado: (2021)

Prevalence of Pseudobulbar Affect (PBA) in Parkinson’s Disease: An Underrecognized Patient Burden
por: Falconer, Ramsey, et al.
Publicado: (2021)

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer’s disease and Parkinson’s disease
por: McGhee, David J. M., et al.
Publicado: (2016)

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study
por: Szwedo, Aleksandra A., et al.
Publicado: (2022)

Comparison of morbidity and mortality of hip and vertebral fragility fractures: Which one has the highest burden?
por: Rizkallah, Maroun, et al.
Publicado: (2020)

Predictors of Burden in Carers of Patients with Impulse Control Behaviors in Parkinson's Disease
por: Johnson, Daniel, et al.
Publicado: (2023)

Child Morbidity and Disease Burden in Refugee Camps in Mainland Greece
por: Kampouras, Asterios, et al.
Publicado: (2019)

Beyond morbidity and mortality: the burden of infectious diseases on healthcare services
por: Colzani, Edoardo
Publicado: (2019)

Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database
por: McLean, Gary, et al.
Publicado: (2017)

Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates
por: Bailey, Freddie, et al.
Publicado: (2019)

Medicated-related burden and adherence in patients with co-morbid type 2 diabetes mellitus and hypertension
por: Baah-Nyarkoh, Emmanuella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q3a0g3qk9h264m23rlkdnt4jc1